INTELLIGENT BIO SOLUTIONS INC. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
INTELLIGENT BIO SOLUTIONS INC. (INBS) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $5.29 million as of 2026-06-30, per its 10-K filed 2026-08-19.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-19
- 2026-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $5.29M.
- 2026-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $8.75M.
- 2025-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $10.89M.
- 2025-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $3.43M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2026-06-30 | $5.29M 10-K · filed 2026-08-19 | |
| 2026-03-31 | $8.75M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $10.89M 10-Q · filed 2026-05-13 | |
| 2025-09-30 | $3.43M 10-Q · filed 2026-05-13 | |
| 2025-06-30 | $2.81M 10-K · filed 2026-08-19 | |
| 2025-03-31 | $4.94M 10-Q · filed 2026-05-13 | |
| 2024-12-31 | $4.20M 10-Q · filed 2026-05-13 | |
| 2024-09-30 | $5.95M 10-Q · filed 2026-05-13 | |
| 2024-06-30 | $8.18M 10-K · filed 2026-08-19 | |
| 2024-03-31 | $11.00M 10-Q · filed 2025-05-13 | |
| 2023-12-31 | $3.15M 10-Q · filed 2025-05-13 | |
| 2023-09-30 | $1.24M 10-Q · filed 2025-05-13 | |
| 2023-06-30 | $3.69M 10-K · filed 2025-08-15 | |
| 2023-03-31 | $5.93M 10-Q · filed 2024-05-08 | |
| 2022-12-31 | $10.26M 10-Q · filed 2024-05-08 | |
| 2022-09-30 | $5.20M 10-Q · filed 2024-05-08 | |
| 2022-06-30 | $6.55M 10-K · filed 2024-09-18 | |
| 2022-03-31 | $8.70M 10-Q · filed 2023-05-11 | |
| 2021-12-31 | $10.04M 10-Q · filed 2023-05-11 | |
| 2021-09-30 | $13.50M 10-Q · filed 2023-05-11 | |
| 2021-06-30 | $15.01M 10-K · filed 2023-08-23 | $15.01M 10-K · filed 2021-09-16 |
| 2021-03-31 | $15.88M 10-Q · filed 2022-05-16 | |
| 2020-12-31 | $18.78M 10-Q · filed 2022-05-16 | |
| 2020-09-30 | -$3.05M 10-Q · filed 2022-05-16 | |
| 2020-06-30 | -$5.21M 10-K · filed 2022-09-22 | |
| 2020-03-31 | -$5.88M 10-Q · filed 2021-05-13 | |
| 2019-12-31 | -$5.87M 10-Q · filed 2021-05-13 | -$5.87M 10-Q · filed 2021-02-12 |
| 2019-09-30 | -$3.89M 10-Q · filed 2021-05-13 | |
| 2019-06-30 | -$3.98M 10-K · filed 2021-09-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |